Antiplaque and antigingivitis effects of a mouthrinse containing cetylpyridinium chloride, triclosan and dipotassium glycyrrhizinate by Shim, Jae-Yong et al.
www.jpis.org
Journal of Periodontal
& Implant Science JPIS
pISSN 2093-2278
eISSN 2093-2286
Copyright © 2012 Korean Academy of Periodontology
This is an Open Access article distributed under the terms of the Creative Commons Attribution  
Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).
Antiplaque and antigingivitis effects of a 
mouthrinse containing cetylpyridinium chloride, 
triclosan and dipotassium glycyrrhizinate
Jae-Yong Shim, Sung-Bin Yim, Jin-Hyung Chung, Ki Seok Hong
*
Department of Periodontology, Dankook University School of Dentistry, Cheonan, Korea
Purpose: The goal of this study was to evaluate the clinical anitplaque and antigingivitis effects of a mouthrinse containing 
cetylpyridinium chloride (CPC), triclosan and dipotassium glycyrrhizinate (DPZ) in patients with gingivitis and mild periodon-
titis.
Methods: Thirty-two subjects were randomized into 2 groups. The test group used a mouthrinse containing 0.05% CPC, 
0.02% triclosan and 0.02% DPZ, while the control group used a placebo mouthrinse. At baseline, 2 weeks and 4 weeks, the 
papillary bleeding index (PBI), Turesky-Quigley-Hein plaque index (PI) and Löe-Silness gingival index (GI) were assessed. Dur-
ing the experimental period, the patients used the mouthrinse for 30 seconds, 4 to 5 times/day (10 mL/time) within 30 minutes 
after toothbrushing.
Results:  No adverse effects appeared in either the experimental or the control group. Regarding PBI, PI and GI values, statis-
tical significance was detected between values at baseline and 2 weeks for both groups (P<0.05). In the experimental group, 
statistically significantly lower values were detected at 4 weeks compared to at 2 weeks. However, in the control group, no sta-
tistically significant difference was detected between the values at 2 weeks and 4 weeks. Additionally, the mean value after 4 
weeks for the control group was slightly higher than the mean value after 2 weeks for the control group.
Conclusions: This study for 4 weeks demonstrated that mouthrinses containing CPC, triclosan and DPZ may contribute to 
the reduction of supragingival plaque and gingivitis.
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INTRODUCTION
The concept of bacterial specificity in periodontal infec-
tions is now widely accepted [1,2]. Three factors are currently 
considered to play a role in establishing an active periodontal 
infection; 1) susceptible host, 2) presence of periodonto-patho-
gens, and 3) absence of beneficial species [3]. The reduction 
of pathogenic microbes and plaque is needed for successful 
treatment because a susceptible host is unlikely to be change 
into an invulnerable one. Previous studies have demonstrat-
ed that long-term stability of the clinical benefits obtained 
via periodontal therapy can be maintained only when cause-
related treatment is followed by effective supportive peri-
odontal care (SPC) [4]. Within this SPC program, self-per-
formed plaque control is crucial in attaining the best long-
term results after periodontal therapy [5].
As patient compliances with mechanical oral hygiene prac-
tices are not always as good as desired, chemical agents have 
been used to improve plaque control and to reduce gingivitis 
[6]. The use of mouthrinse containing antiseptic agents is an 
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effective and feasible way to reduce viable bacteria in the oral 
cavity [7-9]. The antimicrobial and antiplaque effects of vari-
ous mouthrinses have been studied as well [10-12]. Chlorhex-
idine (CHX) is considered as the gold standard among oral 
antiseptics due to its superior clinical and microbiological ef-
fects [13]. However, CHX is known to have undesirable side 
effects, such as tooth staining, burning sensation and soft tis-
sue irritation [10]. As such, a variety of mouthrinse substitutes 
with similar formulas to that of CHX have been studied.
In the present study, mouthrinse containing cetylpyrydini-
um chloride (CPC), triclosan, and dipotassium glycyrrhizinate 
(DPZ) was used. CPC, a cationic surface-active agent, has a 
broad antimicrobial spectrum and can rapidly kill particular 
gram-positive pathogens and yeast [14]. Several studies have 
reported that a mouthrinse containing 0.05% CPC is effica-
cious in controlling established dental plaque and gingivitis 
[15]. Triclosan, a broad spectrum antimicrobial agent, has been 
widely used in mouthrinses and dentifrices. It acts as an anti-
bacterial agent by inhibiting the enoylreductase activity of 
the type II fatty acid synthase in bacteria [16]. There have been 
studies which reported triclosan mouthrinse to have a con-
tinuous disinfecting effect and to be helpful in controlling 
dental plaque formation and adhesion [17,18]. DPZ, a compo-
nent of licorice root, has been known to have detoxicant, an-
ti-ulcerative and anti-inflammatory effects. It is already being 
used as a component of mouthrinses in Japan. There is a pu-
blished article that demonstrated mouthrinses containing 
0.05% CPC and 0.015% DPZ were useful in preventing peri-
odontal disease [19]. Previous studies have assessed each of 3 
components (CPC, triclosan, DPZ) independently, however 
there is not any study that has reported the effect of a mouth-
rinse containing a combination of all 3 components.
The goal of this study was to evaluate the clinical antiplaque 
and antigingivitis effects of a mouthrinse containing CPC, 
triclosan and DPZ in patients with gingivitis and mild peri-
odontitis.
MATERIALS AND METHODS
Patient selection
This study was performed at the Department of Periodon-
tology, Dankook University School of Dentistry, Korea. Thir-
ty-two subjects who met the following inclusion criteria were 
entered into the study: 1) a minimum of 20 sound, natural 
teeth, 2) healthy and without any history of allergies to exper-
imental mouthrinses, 3) a mean Turesky-Quigley-Hein plaque 
index (PI) of at least 1.5, and 4) a mean Löe-Silness gingival 
index (GI) of at least 1.0. Subjects with orthodontic applianc-
es, removable partial dentures, intraoral lesions, and severe 
periodontal disease, as well as those currently using other 
mouthrinses were all excluded. 
In this clinical study, 3 patients who did not visit our clinic 
on the appropriate dates were excluded. Written informed 
consent was obtained from all subjects. The protocol for hu-
man subjects was reviewed and approved by the Institutional 
Review Board of Dankook University in 2011 (H-1102-001-
002). The study was conducted in accordance with the Hel-
sinki Declaration of 1975, as revised in 2000. Inclusion and 
exclusion criteria are as follows.
Experimental material 
The test group used GUM Dental Rinse GNN (GUM, Sun-
star Inc., Osaka, Japan) while the control group used a place-
bo mouthrinse. GUM Dental Rinse GNN is a mouthrinse 
containing 0.05% CPC, 0.02% triclosan and 0.02% DPZ. The 
placebo mouthrinse did not contain CPC, triclosan or DPZ. A 
disclosing solution was used to evaluate the PI. During the 
experimental period, the patients used a smooth tooth brush 
and a custom-made toothpaste without sodium lauryl sulfate. 
Clinical parameter
Patients were evaluated using the PBI, Turesky-Quigley-
Hein PI and Löe-Silness GI. Plaque accumulation was evalu-
ated via the Turesky-Quigley-Hein PI. This index emphasizes 
differences in plaque accumulation in the gingival one-third 
of the tooth and tends to overestimate the incisal one-half of 
the crown, at the expense of the gingival margin. The scoring 
system was as follows:
0=  no plaque;
1=   separate flecks of plaque at the cervical margin of the 
tooth;
2=   a thin continuous band of plaque (up to 1 mm) at the 
cervical margin of the tooth;
3=   a band of plaque wider than 1 mm but covering less 
than one-third of the crown of the tooth;
4=   plaque covering at least one-third but less than two-
thirds of the crown of the tooth;
5=   plaque covering two-thirds or more of the crown of the 
tooth.
Gingivitis was evaluated using the PBI and GI. 
The PBI was based on bleeding following gentle probing of 
the interdental papilla:
0=no bleeding;
1=a single discrete bleeding point appears;
2=several isolated bleeding points on a small area of blood;
3=interdental triangle filled with blood;
4=profuse  bleeding spreading toward the gingival margin.
The GI was designed to estimate different degrees of in-
flammation in the marginal gingiva. The severity of inflam-
matory change was scored from 0 to 3, as follows:Journal of Periodontal
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0=absence of inflammation;
1=   mild inflammation; slight change in color and little 
chan  ge in texture; 
2=   moderate inflammation; moderate glazing, redness, 
ede  ma, and hypertrophy; bleeding on pressure; 
3=   severe inflammation; marked redness and hypertrophy; 
tendency to spontaneous bleeding; ulceration.
Experimental design
Before the experiment, the patients in both the test group 
and the control group received an oral prophylaxis and tooth-
brushing instruction. The clinical parameters (GI, PBI, and 
PI) were measured at baseline, 2 weeks and 4 weeks. During 
the experimental period, patients used the mouthrinse 4 to 5 
times a day for 30 seconds with 10 mL. They used the mouth-
rinse within 30 minutes after toothbrushing. The experimen-
tal protocol is described in Fig. 1 and Table 1. 
Statistical analysis
The differences in clinical parameters among the values at 
baseline, 2 weeks and 4 weeks for each group were evaluated 
using the Wilcoxon signed rank test. The differences between 
the test group and control group were evaluated using the 
Mann-Whitney test. The value of α was 0.05. These analyses 
were conducted using SPSS ver. 12.0 (SPSS Inc., Chicago, IL, 
USA).
RESULTS
Discoloration of the teeth and tongue, taste alteration, mu-
cosal irritation, hypersensitivity, discomfort during use, and a 
feeling of irritation did not appear in either the experimental 
or the control group. 
PBI (Table 2)
The mean PBI value was 0.577 in the experimental group 
and 0.529 in the control group, both at baseline. Statistical 
significances were detected between values at baseline and 2 
weeks in both groups (P<0.05). Between 2 weeks and 4 weeks, 
changes in the PBI values displayed different patterns be-
tween the experimental and control groups. Statistically sig-
nificant difference was found between values at 2 weeks and 
4 weeks for the experimental group, as values were lower at 4 
weeks (P<0.05). However, for the control group, no statisti-
cally significant difference was detected between values at 2 
weeks and 4 weeks. The mean PBI value after 4 weeks for the 
control group was slightly higher than the mean PBI value 
after 2 weeks for the control group (Fig. 2).
PI (Table 2)
The mean PI was 1.813 for the experimental group and 1.917 
Table 1. Experimental protocol.
Examination details
Screening
Visit 0 (-1 week) Visit 1 (Baseline) Visit 2 (2 weeks) Visit 3 (4 weeks)
Experimental consent V
Demographic investigation V
Medical/dental history V
Inclusion/exclusion evaluation V
P  laque accumulation evaluation (Turesky-Quigley-Hein plaque index) V V V
G  ingival inflammation evaluation (Löe-Silness gingival index) V V V
G  ingival inflammation evaluation (papillary bleeding index) V V V
-1 week
Oral exam
Oral exam
Screening
Randomization
Use of GNN 4-5 times a day
(after meals, before sleeping)
Plaque index
Gingival index
Papilla bleeding index
0 week 2 weeks 4 weeks
Figure 1. Experimental protocol.
Table 2. Mean values of the clinical parameters.
Baseline (0 week) After 2 weeks After 4 weeks
Experimental group
PBI 0.577±0.17 0.357±0.10 0.310±0.31
PI 1.813±0.39 1.181±0.58 1.068±0.51
GI 1.261±0.26 0.788±0.27 0.688±0.29
Control group
PBI 0.529±0.24 0.286±0.20 0.338±0.18
PI 1.91±0.52 1.372±0.61 1.457±0.49
GI 1.110±0.11 0.759±0.33 0.838±0.26
Values are presented as mean±SD.
PBI: papillary bleeding index, PI: Turesky-Quigley-Hein plaque index, GI: Löe-
Silness gingival index. Journal of Periodontal
& Implant Science JPIS
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for the control group, both at baseline. Statistical significance 
was shown between values at baseline and 2 weeks in both 
groups (P<0.05). A statistically significant difference was fo-
und between the values at 2 weeks and 4 weeks for the ex-
perimental group, as values were lower at 4 weeks (P<0.05). 
After 4 weeks, the mean PI value in the control group was 
slightly higher than at 2 weeks, without any statistical signifi-
cance (Fig. 3).
GI (Table 2)
The mean GI was 1.261 in the experimental group and 1.110 
in the control group, both at baseline. 
Statistical significance was observed between the values at 
baseline and 2 weeks for both groups (P<0.05). A statistically 
significant difference was found between the values at 2 weeks 
and 4 weeks for the experimental group, as values were lower 
at 4 weeks (P<0.05). However, in the control group, no statis-
tically significant difference was detected between the values 
at 2 weeks and 4 weeks. Additionally, for the control group, 
slightly higher GI values were detected between 2 weeks and 
4 weeks (Fig. 4).
DISCUSSION
The present study demonstrated that mouthrinses contain-
ing CPC, triclosan, and DPZ produced significant reductions 
in supragingival plaque and gingivitis.
Previous studies have compared the efficacy of various mou-
thrinses using the Turesky-Quigley-Hein PI for evaluation of 
plaque accumulation and the Löe-Silness GI for gingivitis 
evaluation [20-23]. In other previous studies, PBI was an ex-
cellent parameter for the measurement of the severity of 
gingival inflammation [24]. Therefore, in this study, plaque 
accumulation was measured using the Turesky-Quigley-Hein 
PI while gingivitis was measured using the Löe-Silness and 
papilla bleeding indexes. 
Statistical significance was detected between the values at 
baseline and 2 weeks for both groups with regard to PBI, PI 
and GI (P<0.05). It seems that both the experimental group 
and the control group displayed noticeable differences be-
cause the effects of scaling and polishing were sustained. 
However, between 2 weeks and 4 weeks, the change in the 
PBI, PI and GI values showed significant differences only in 
the experimental groups. This observation is in agreement 
with other previous studies. Zimmer et al. [25] reported that 
CPC containing mouthrinses decreased PBI scores over the 
course of 8 weeks. Mankodi et al. [26] and Allen et al. [27] re-
ported in a 6-month clinical study that an increased PI score 
decreased when CPC-containing mouthrinses were as used, 
compared with results when placebo mouthrinses were used. 
Other authors have reported that the GI score decreased when 
CPC-containing mouthrinses were used. [27,28] 
When changes in the experimental group and in the con-
trol group were compared, , the experimental group showed 
a continuous decrease while the control group showed a 
slight increase following an initial decrease until 2 weeks. 
Charles et al. [29] compared a CHX group, an essential oil 
group, and a control group. The authors found that the CHX 
Figure 2. Papillary bleeding index. 
a)Statistically significant (P<0.05).
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0
Baseline 2 weeks 4 weeks
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Experimental
Control
Figure 3. Plaque index. 
a)Statistically significant (P<0.05).
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Figure 4. Gingival index. 
a)Statistically significant (P<0.05).
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and essential oil groups showed decreasing GI and PI scores, 
but the control group showed an initial decreasing trend be-
fore a subsequent increase of the scores. This indicates that 
scaling and polishing were effective only at the initial stage. 
Therefore, applying mouthrinses after such procedures can 
contribute to prevention of plaque accumulation and gingi-
vitis.
In previous studies using CPC-containing mouthrinse, there 
was not any significant difference between the group using 
CPC mouthrinse and a control group [25-29]. In contrast, with-
in the present study, clinical indexes in the group using a mou-
thrinse containing a combination of CPC, triclosan, and DPZ 
was significantly different from the control group. This may 
not serve as evidence of synergistic effects in these 3 compo-
nents, but we can assume that two other antimicrobial ac-
tions and an anti-inflammatory effect would maximize the 
contribution for periodontal health. In order to more com-
paratively evaluate efficacy between a group using a CPC-on-
ly mouthrinse and another group using a mouthrinse con-
taining a combination of all 3 components, a more precise 
experimental design will be needed. In a longer period of trial, 
since anti-inflammatory reaction may bring reduced probing 
depth and gained attachment level, these factors should also 
be considered in the future study. 
Nevertheless, in this study, mouthrinses containing CPC, 
triclosan, and DPZ showed positive effect on clinical indexes 
with statistical significance. However, to draw more definite 
conclusions regarding the efficacy of mouthrinses contain-
ing all 3 agents, future studies should include longer obser-
vation periods at least 6 months and larger sample sizes, as 
well as a microbiological focus. 
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